Adicet Bio (ACET)
(Real Time Quote from BATS)
$1.42 USD
-0.01 (-0.70%)
Updated Sep 24, 2024 12:28 PM ET
2-Buy of 5 2
F Value D Growth D Momentum F VGM
Adicet Bio, Inc. (ACET) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$6.75 | $8.00 | $5.00 | 372.03% |
Price Target
Based on short-term price targets offered by four analysts, the average price target for Adicet Bio, Inc. comes to $6.75. The forecasts range from a low of $5.00 to a high of $8.00. The average price target represents an increase of 372.03% from the last closing price of $1.43.
Analyst Price Targets (4 )
Broker Rating
Adicet Bio, Inc. currently has an average brokerage recommendation (ABR) of 1.75 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by eight brokerage firms. The current ABR compares to an ABR of 1.50 a month ago based on eight recommendations.
Of the eight recommendations deriving the current ABR, five are Strong Buy, representing 62.5% of all recommendations. A month ago, Strong Buy represented 75%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 5 | 5 | 6 | 6 | 6 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 3 | 3 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.75 | 1.75 | 1.50 | 1.50 | 1.50 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/11/2024 | H.C. Wainwright & Co. | Edward White | Strong Buy | Hold |
8/14/2024 | Canaccord Genuity | John L Newman | Strong Buy | Strong Buy |
8/13/2024 | Wedbush Securities | Robert Driscoll | Strong Buy | Strong Buy |
4/16/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
3/21/2024 | Guggenheim Securities | Michael Schmidt | Hold | Hold |
3/20/2024 | Truist Securities | Asthika S Goonewardene | Strong Buy | Strong Buy |
2/2/2024 | JMP Securities | Reni Benjamin | Hold | Hold |
1/7/2024 | BTIG | Justin R Zelin | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.75 |
ABR (Last week) | 1.75 |
# of Recs in ABR | 8 |
Average Target Price | $6.75 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 80 of 253 |
Current Quarter EPS Est: | -0.34 |
ACET FAQs
Adicet Bio, Inc. (ACET) currently has an average brokerage recommendation (ABR) of 1.75 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 8 brokerage firms.
The average price target for Adicet Bio, Inc. (ACET) is $6.75. The current on short-term price targets is based on 3 reports.
The forecasts for Adicet Bio, Inc. (ACET) range from a low of $5 to a high of $8. The average price target represents a increase of $372.03 from the last closing price of $1.43.
The current UPSIDE for Adicet Bio, Inc. (ACET) is 372.03%
Based on short-term price targets offered by four analysts, the average price target for Adicet Bio, Inc. comes to $6.75. The forecasts range from a low of $5.00 to a high of $8.00. The average price target represents an increase of 372.03% from the last closing price of $1.43.